Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
Authors:
Open Access
- 29 November 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 1020583
Abstract
Colorectal cancer(CRC) is the third most frequent malignant tumor. The gut microbiome acts as a vital component of CRC etiology. Fusobacterium nucleatum(Fn) is a key member of colorectal cancer-associated bacteria. But we lack a systematic and in-depth understanding on its role in CRC evolution. In this article, We reviewed the abundance changes and distribution of Fn in CRC occurrence and development, potential effect of Fn in the initiation of CRC, the source of intratumoral Fn and the cause of its tropism to CRC. In addition, We described the mechanism by which Fn promotes the malignant biological behavior of CRC, affects CRC response to therapy, and shapes the tumor immune microenvironment in great detail. Based on the relationship between Fn and CRC, we proposed strategies for CRC prevention and treatment, and discussed the feasibility and limitations of specific cases, to gain insights into further basic and clinical research in the future.Keywords
This publication has 143 references indexed in Scilit:
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- Fusobacterium nucleatumadhesin FadA binds vascular endothelial cadherin and alters endothelial integrityMolecular Microbiology, 2011
- Genomic analysis identifies association of Fusobacterium with colorectal carcinomaGenome Research, 2011
- Fusobacterium nucleatum infection is prevalent in human colorectal carcinomaGenome Research, 2011
- Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the hostInflammatory Bowel Diseases, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Tumor-Initiating Cells Are Rare in Many Human TumorsCell Stem Cell, 2010
- Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell linesBritish Journal of Pharmacology, 2009
- Chronic Liver Disease Impairs Bacterial Clearance in a Human Model of Induced BacteremiaClinical and Translational Science, 2009
- NUMB controls p53 tumour suppressor activityNature, 2008